Vaibhav Agrawal, Chief Investment Officer, Teji Mandi, shares investment insights.
The Nifty Pharma index closed at record highs of 13,426 gaining 1.29% on Tuesday, while the benchmark Nifty index ended below 14,300-mark at 14,296 af
In FY22 Nifty can deliver 15-20% returns, but before that, it could correct 5-7% or 700-1000 points
Domestic brokerage firm Motilal Oswal believes Steel Authority of India Limited (SAIL) is the best play on higher steel prices and has a price target
Time in the equity market is important than timing the market. Historical data also support the old saying. The benchmark BSE Sensex has advanced over